Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416.

Source:http://linkedlifedata.com/resource/pubmed/id/18555591

Cancer Lett. 2008 Nov 8 270 2 260-8

Download in:

View as

General Info

PMID
18555591